• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者的颈动脉粥样硬化

Carotid atherosclerosis in renal transplant recipients.

作者信息

Massy Z A, Mamzer-Bruneel M F, Chevalier A, Millet P, Helenon O, Chadefaux-Vekemans B, Legendre C, Bader C, Drüeke T, Lacour B, Kreis H

机构信息

Service de Transplantation, Laboratoire de Biophysique and INSERM U90, Hôpital Necker, Paris, France.

出版信息

Nephrol Dial Transplant. 1998 Jul;13(7):1792-8. doi: 10.1093/ndt/13.7.1792.

DOI:10.1093/ndt/13.7.1792
PMID:9681730
Abstract

BACKGROUND

Cardiovascular accidents are the major cause of morbidity and mortality in renal transplant recipients. However, there is little information concerning carotid atherosclerotic wall changes in renal transplant recipients, their relationship with cardiovascular accidents and their possible association with cardiovascular risk factors in such patients.

METHODS

Between April 1991 and December 1997, we prospectively assessed cardiovascular accidents in 79 renal transplant recipients who had received a transplant at our institution before January 1, 1986. Carotid morphology by B-mode ultrasonography, relevant clinical and laboratory cardiovascular risk factors, including lipid abnormalities and total homocyst(e)ine, were determined at the start of the follow-up period. Seventeen healthy subjects matched for age and sex with renal transplant recipients served as controls who volunteered for ultrasonographic examination of carotid arteries.

RESULTS

Nine patients experienced cardiovascular events during the period of follow-up. Compared with healthy, age- and sex-matched control subjects (n = 17), the frequency of carotid plaques was higher in renal transplant recipients with cardiovascular events (n = 9), but not in those without such events (n = 70). The frequency of cardiovascular accidents was related to the number of carotid plaques (4, 17 and 24% for no plaque, one plaque and > 1 plaque respectively, P < 0.04). However, by multivariate analysis, serum total cholesterol [odds ratio (OR) of 1.8 for each 1.0 mM, P < 0.07) and the presence of diabetes mellitus (OR of 28.4 for presence, P < 0.01) were the only predictors of cardiovascular events in such patients, whereas the presence of carotid plaques was not. Moreover, neither serum lipoprotein (a) nor total homocyst(e)ine concentrations could be identified as risk factors.

CONCLUSIONS

This prospective study shows that although a close association exists between asymptomatic carotid atherosclerosis and cardiovascular accidents in renal transplant recipients with long-term follow-up and relatively good renal function, other potentially modifiable risk factors appear to be better predictors of cardiovascular events. Consequently, the assessment of carotid atherosclerosis may not be clinically useful for the systematic identification of renal transplant recipients with an increased risk of developing cardiovascular events.

摘要

背景

心血管意外是肾移植受者发病和死亡的主要原因。然而,关于肾移植受者颈动脉粥样硬化壁改变、其与心血管意外的关系以及与这类患者心血管危险因素的可能关联的信息很少。

方法

在1991年4月至1997年12月期间,我们前瞻性评估了79例于1986年1月1日前在本机构接受移植的肾移植受者的心血管意外情况。在随访期开始时,通过B型超声检查颈动脉形态,测定相关临床和实验室心血管危险因素,包括脂质异常和总同型半胱氨酸。17名年龄和性别与肾移植受者匹配的健康受试者作为对照,自愿接受颈动脉超声检查。

结果

9例患者在随访期间发生心血管事件。与健康的、年龄和性别匹配的对照受试者(n = 17)相比,发生心血管事件的肾移植受者(n = 9)颈动脉斑块的发生率更高,但未发生此类事件的肾移植受者(n = 70)并非如此。心血管意外的发生率与颈动脉斑块数量相关(无斑块、有1个斑块和有>1个斑块的发生率分别为4%、17%和24%,P < 0.04)。然而,通过多变量分析,血清总胆固醇(每增加1.0 mM的比值比(OR)为1.8,P < 0.07)和糖尿病的存在(存在时的OR为28.4,P < 0.01)是这类患者心血管事件的唯一预测因素,而颈动脉斑块的存在则不是。此外,血清脂蛋白(a)和总同型半胱氨酸浓度均不能被确定为危险因素。

结论

这项前瞻性研究表明,尽管在长期随访且肾功能相对良好的肾移植受者中,无症状颈动脉粥样硬化与心血管意外之间存在密切关联,但其他潜在可改变的危险因素似乎是心血管事件更好的预测因素。因此,颈动脉粥样硬化的评估对于系统识别发生心血管事件风险增加的肾移植受者可能在临床上并无用处。

相似文献

1
Carotid atherosclerosis in renal transplant recipients.肾移植受者的颈动脉粥样硬化
Nephrol Dial Transplant. 1998 Jul;13(7):1792-8. doi: 10.1093/ndt/13.7.1792.
2
Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins.肾移植受者的颈动脉粥样硬化:与心血管危险因素及血浆脂蛋白的关系。
Transplantation. 1999 Feb 15;67(3):366-71. doi: 10.1097/00007890-199902150-00005.
3
Impact of carotid atherosclerosis as assessed by B-mode ultrasonography on the evolution of kidney transplantation.通过B型超声评估的颈动脉粥样硬化对肾移植进展的影响。
Transplant Proc. 2007 Sep;39(7):2236-8. doi: 10.1016/j.transproceed.2007.06.062.
4
[Prevalence of atherosclerosis in renal transplant recipients].
Minerva Cardioangiol. 2001 Aug;49(4):229-38.
5
Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.高同型半胱氨酸血症、糖尿病和颈动脉粥样硬化各自独立增加日本终末期肾病患者的动脉粥样硬化性血管疾病结局。
Clin Nephrol. 2001 Aug;56(2):132-9.
6
Dissociation between carotid artery lesions and lipid parameters in recipients of successful kidney graft.成功肾移植受者颈动脉病变与血脂参数之间的分离
Diabetes Nutr Metab. 2003 Aug;16(4):232-5.
7
Effect of Immunosuppressive Treatment on Carotid Atherosclerosis in Renal Transplant Recipients.免疫抑制治疗对肾移植受者颈动脉粥样硬化的影响。
Transplant Proc. 2016 Jun;48(5):1626-9. doi: 10.1016/j.transproceed.2016.03.005.
8
[Association between carotid artery plaques and all-cause mortality and cardiovascular events].颈动脉斑块与全因死亡率及心血管事件之间的关联
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1086-1090. doi: 10.3760/cma.j.issn.0253-3758.2017.12.014.
9
Progression of macrovascular disease after transplantation.移植后大血管疾病的进展
Transplantation. 2000 Feb 27;69(4):574-81. doi: 10.1097/00007890-200002270-00019.
10
Carotid intima-media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery.肾移植儿童和青年的颈动脉内膜中层厚度:颈内动脉与颈总动脉的比较
Pediatr Transplant. 2007 Dec;11(8):888-94. doi: 10.1111/j.1399-3046.2007.00760.x.

引用本文的文献

1
Statin use is associated with prolonged survival of renal transplant recipients.使用他汀类药物与肾移植受者的长期存活相关。
J Am Soc Nephrol. 2008 Nov;19(11):2211-8. doi: 10.1681/ASN.2008010101. Epub 2008 Jul 23.
2
Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.免疫抑制剂对肾移植受者长期生存的影响:聚焦心血管风险。
Drugs. 2004;64(18):2047-73. doi: 10.2165/00003495-200464180-00004.
3
The metabolic effects of cyclosporin and tacrolimus.
J Endocrinol Invest. 2000 Jul-Aug;23(7):482-90. doi: 10.1007/BF03343761.